It is definitely oversold.. The company is doing just fine.. the CEO will be replaced, likely for someone better. This will get back up there, it will just likely take more time now, probably in 2017 will it start to show kind numbers.
Now is a great entry though. There was not another recall, they arent doing bad. Surgeons still like them based on existing patients and their feedback.
It is still the #1 joint replacement technology. They still have around 500 patents!
Buying in at this price is going to give you a nice future.
News 
Market Data 
Discover 
AI
